Table 1 Patient characteristics
Characteristic | Total (n = 26) | 18 Gy (n = 12) | 21 Gy (n = 14) | p-value |
|---|---|---|---|---|
No. of patients (%) | ||||
Median age (range) | 74 years (54–84) | 74 years (66–80) | 73 years (54–84) | 0.860 |
T stage | 0.297 | |||
2b | 1 (4) | 0 (0) | 1 (7) | |
2c | 2 (8) | 0 (0) | 2 (14) | |
3a | 14 (54) | 7 (58) | 7 (50) | |
3b | 5 (19) | 3 (25) | 2 (14) | |
4 | 4 (15) | 2 (17) | 2 (14) | |
Grade group | 0.462 | |||
1 | 1 (4) | 0 (0) | 1 (7) | |
2 | 2 (8) | 2 (17) | 0 (0) | |
3 | 2 (8) | 1 (8) | 1 (7) | |
4 | 8 (30) | 4 (34) | 4 (29) | |
5 | 13 (50) | 5 (42) | 8 (57) | |
Initial PSA (ng/mL) | 0.252 | |||
< 10 | 5 (19) | 1 (8) | 4 (29) | |
10–20 | 3 (12) | 1 (8) | 2 (14) | |
> 20 | 18 (69) | 10 (83) | 8 (57) | |
Risk group | 0.781 | |||
High | 1 (4) | 0 (0) | 1 (7) | |
Very high | 25 (96) | 12 (100) | 13 (93) | |
Median duration of ADT, months (range) | 25 (9–35) | 26 (20–34) | 25 (9–35) | 0.742 |
Baseline OABSS (0–15) | 0.781 | |||
0–5 (mild) | 23 (88) | 11 (92) | 12 (86) | |
6–11 (moderate) | 2 (8) | 1 (8) | 1 (7) | |
12–15 (severe) | 1 (4) | 0 (0) | 1 (7) | |
Baseline IPSS (0–35) | 0.231 | |||
1–7 (mild) | 7 (27) | 5 (42) | 2 (14) | |
8–19 (moderate) | 16 (62) | 6 (50) | 10 (72) | |
20–35 (severe) | 3 (11) | 1 (8) | 2 (14) | |
Baseline QoL | 0.036 | |||
Delighted | 5 (19) | 5 (42) | 0 (0) | |
Pleased | 5 (19) | 1 (8) | 4 (29) | |
Mostly satisfied | 4 (15) | 2 (17) | 2 (14) | |
Mixed | 7 (27) | 2 (17) | 5 (36) | |
Mostly dissatisfied | 3 (12) | 1 (8) | 2 (14) | |
Unhappy | 2 (8) | 1 (8) | 1 (7) | |
Terrible | 0 (0) | 0 (0) | 0 (0) | |